BOL: Related items

Gupta Lab

Sun, 15 Sep 2013 09:31:24 -0500

Gupta laboratory of Natural Information Processing at DA-IICT. Research in our lab currently focuses on two aspects of information processing viz. deciphering the information processing principles in life (systems biology) and making a computer out of bio-molecules. The key expertise of the lab is in error-correcting codes. We also work in classical and quantum information processing principles with expertise in coding theory and its wide variety of applications in Information and Communication Technology (ICT).

More @ http://www.guptalab.org/

Genomics and sequencing approach for identification of biomarkers to assess the efficacy of TGF-βRI inhibitors (of liver cancer) in vivo

Rahul Agarwal — Tue, 05 Aug 2014 13:55:32 -0500

Liver cancer is third leading cause of deaths and fourth most frequent occuring cancer worldwide. There are multiple signaling pathways responsible for causing cancer amongst which TGFb is most important cytokine whose signaling pathway promote cancer. However, main problem is to cure this cancer at late stage where we still have no treatment strategy to tackle this deadly cancer. Hence we need to find out new therapeutic target. One way is to look the relationships between mRNA, methylation and miRNA data of patients with different pathological conditions (cancer vs control either with inhibitor/not). MiRNA is small RNA molecules known to inhibit mRNA expression of particular gene by binding improperly to 3'UTR region of a gene and hence block binding of TF /translation of gene. CpG regions is known to located at promoter region of gene (5' UTR) and usually hypomethylated which allow to gene to transcribe and translate however sometime this region become hyper-methylated thats prevent expression of host gene. Thus , integration of these three data reveal new targets and pathways important for causing or preventing cancer and also reveal biomarker thats check the effects of inhibitor on signaling pathway underlying liver cancer.

Sidow Lab

Fri, 07 Dec 2018 09:06:30 -0600

We study mechanisms of cancer evolution by using state-of-the-art genomic approaches at the bench and in analysis. Accurate genome reconstruction is our other major area of interest. We also collaborate on important questions for which our expertise in genomics and computation is relevant. Arend's biosketch highlights some of our past contributions.

http://www.sidowlab.org/

Gamper Lab

Fri, 26 Mar 2021 07:45:02 -0500

Lab focuses on examining the mechanisms governing the signalling pathways from DNA damage sensing to the activation of stress-response genes. The long-term goal is to find proteins that are drug targets for cancer treatment (such as radiosensitizers for radiation therapy) or biomarkers that increase the predictive value of therapeutic outcome.

https://amgamper.weebly.com/

Ragan Lab

Sun, 14 Jul 2013 12:03:43 -0500

Computational systems biology

Research Area:
breast cancer; pancreatic cancer; prostate cancer; gastrointestinal disorders; urohaemolytic disorders; staphylococcal diseases

Mathivanan Lab

Fri, 20 Sep 2013 13:09:38 -0500

The major research interests are in exploring the role of extracellular matrix components (soluble secreted proteins and membrane vesicles) in cancer and intercellular communication. The lab integrates proteomic, genomic and bioinformatics methodologies to explore cancer cells.

More at http://www.mathivananlab.org/index.html

http://scholar.google.com/citations?user=U6PyEdYAAAAJ&hl=en

Huber Lab

Mon, 09 Sep 2013 21:57:03 -0500

The Huber group develops computational and statistical methods to design and analyse novel experimental approaches in genetics and cell biology.

Future projects and goals

Large-scale systematic maps of gene-gene and gene-environment interactions by automated phenotyping, using image analysis, machine learning, sparse model building and causal inference.
DNA-, RNA- and ChIP-Seq and their applications to gene expression regulation: statistical and computational foundations.
Cancer genomics, genomes as biomarkers, cancer phylogeny.
Image analysis for systems biology: measuring the dynamics of cell cycle and of cell migration of individual cells under normal conditions and many different perturbations (RNAi, drugs).

More @ http://www.embl.de/research/units/genome_biology/huber/index.html

Immune response to cancer cells! AWESOME

Fri, 20 Sep 2013 06:20:47 -0500

Awesome viddeo explaining the way in which the antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein that is only expressed on the surface of myeloma cells. This initiates antibody-dependent cellular cytotoxicity activity that kills myeloma cells and leaves healthy cells intact.

Yau Group

Tue, 15 Oct 2013 13:05:15 -0500

Yau Group are a new research group based at the Wellcome Trust Centre for Human Genetics and the Department of Statistics at the University of Oxford.

Yau Group develops statistical and computational methods for the analysis of genomic datasets with a particular interest in cancer sequencing applications and the use of Bayesian Statistics.

Yau Group are currently have projects in somatic mutation analysis of heterogeneous cancers, data fusion or integration techniques and single cell genomics.

More @ http://www.well.ox.ac.uk/~cyau/index.html

Bioinformatics @ TATA MEMORIAL CENTRE, NAVI MUMBAI

Mon, 28 Oct 2013 10:40:25 -0500

TATA MEMORIAL CENTRE
ADVANCED CENTRE FOR TREATMENT, RESEARCH AND EDUCATION IN CANCER
KHARGHAR, NAVI MUMBAI – 410210

No. ACTREC/Advt./ 72 /2013

WALK IN INTERVIEW

1. JRF*
Genome-wide RNAi screen with human pooled tyrosine kinase shRNA libraries in head and neck squamous call carcinoma (HNSCC) cell lines
DBT A/C No. 3071, Dr. Amit Dutt

2. JRF
IRB Project ACTREC Funds
Dr. Amit Dutt

3. RA
Defining the cancer genome of Head and Neck Squamous Cell Carcinoma (HNSCC) with SNP arrays and next generation sequencing technology
A/C No. 2895, Dr. Amit Dutt

Duration of the Project: One year from the date of appointment, or as and when project terminates.

Consolidated Salary: RA : Rs. 40,000/- p.m.
JRF* (DBT): Rs. 20,800/- p.m.
JRF: Rs. 16,000/- p.m.
Date & Time: 6th November, 2013, at 10.00 a.m.

Venue: Conference Room

Minimum Qualifications and Experience:

RA: The ideal applicant should have a PhD in a relevant field. He/she should have a strong computational biology background, with demonstrated experience in coding using Perl, Python, Java or C++. He/she should be familiar with working in unix enviromnent, devising computational algorithms for data analysis, statistical data analysis in R and matlab and database programming using MySQL. Hands on experience in analyzing high throughput data would be an added advantage.

JRF* (DBT project): M.Sc. in Life Sciences or M.Tech in Biotechnology with good academic record (Minimum of 60% aggregate). Valid UGC-CSIR/DBT/ICMR JRF qualification and laboratory experience in molecular biology. Previous experience in molecular biology and animal tissue culture with high throughput platforms and ability to work with a large team would be desirable.

JRF (ACTREC project): M.Sc. in Life Sciences or M.Tech in Biotechnology with good academic record (Minimum of 60% aggregate). Minimum 2 yrs experience in molecular biology and animal tissue culture with high throughput platforms and ability to work with a large team is essential.

*M.Sc. degree obtained after a one year course will not be considered.

Candidates fulfilling above requirements should send their application by e-mail to
‘careers.duttlab@gmail.com. in the format given below so as to reach on or before
4th November, 2013.

http://www.actrec.gov.in/data%20files/2013/AD-RA-JR-TECHN-6-NOV.pdf